Microfabricated Device Developed at Mass General Allows Evaluation of the Efficacy, Toxicity of Drugs Metabolized Through the Liver


A team of researchers from the Mass General Center for Engineering in Medicine (CEM) has developed a new microfabricated device that simplifies the process of testing so-called “pro-drugs” for toxic side effects.

A pro-drug is one that is administered in an inactive form and then transformed into an active drug via metabolism in the liver. The device created by the CEM team has separate chambers for two sets of cell cultures.

In the example used in the study, one chamber contained liver cells and the other contained cancer cells. A chemotherapy pro-drug designed to treat the cancer cells was then introduced to the liver cell culture, allowing researchers to observe the metabolism of the drug and the interaction between the two cultures to see if any potentially toxic byproducts resulted. Shyam Sundhar Bale, PhD, was lead author of the study.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s